FDA approves 5+ novel drugs in 2027 under new commissioner

Makary's departure suggests a potential acceleration in drug approvals due to reduced bureaucratic friction. With a new commissioner likely prioritizing efficiency, the agency may approve at least 5 novel drugs this year, up from 3 in 2024.

Implied probability (Yes)

70%

Closes

2027-12-31